FDA product code OJQ: Cardiac Allograft Gene Expression Profiling Test System

OJQ is the FDA product code for cardiac allograft gene expression profiling test system. It is a Class II device, regulated under 21 CFR 862.1163 and reviewed by the Clinical Chemistry panel. FDA has cleared 1 510(k) submission under OJQ, 1 in the last five years. The average 510(k) review took 464 days (median 464). 1 De Novo request was granted under it.

Definition

In vitro diagnostic multivariate index assay (ivdmia) test service, performed in a single laboratory, for assessing the gene expression profile of rna isolated from peripheral blood mononuclear cells (pbmc) and indicated for use to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (acr) at the time of testing in conjunction with standard clinical assessment.

Classification

FieldValue
Device nameCardiac Allograft Gene Expression Profiling Test System
Device classClass II
Regulation21 CFR 862.1163
Review panelCH — Clinical Chemistry
Medical specialtyCardiovascular
Premarket route510(k)

510(k) clearances per year for OJQ

YearClearancesAvg. review days
20231464

Compare with all 510(k) review times · Search every OJQ clearance

Top OJQ applicants

ApplicantClearancesLatest
Caredx, Inc.12023-09-13

Most recent OJQ clearances

510(k)ApplicantDeviceDecision dateReview days
K221640Caredx, Inc.AlloMap Heart Molecular Expression Testing2023-09-13464

Recalls for OJQ devices

openFDA lists no recalls for product code OJQ.

Frequently asked questions

What is FDA product code OJQ?

OJQ is the FDA product code for cardiac allograft gene expression profiling test system. It is a Class II device, regulated under 21 CFR 862.1163 and reviewed by the Clinical Chemistry panel.

What device class is OJQ?

Class II, regulation 21 CFR 862.1163. Typical premarket route: 510(k).

How long does a 510(k) take for product code OJQ?

Across 1 cleared submissions the average was 464 days from receipt to decision (median 464).

Which companies have the most OJQ clearances?

Caredx, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times